WXIBF fundamentals
An in-depth look to Wuxi Biologics Cayman Inc. operating, investing, and financing activities
WXIBF free cash flow for H2 23 is 38.51 M USD. For 2023, WXIBF free cash flow was 63.32 M USD and operating cash flow was 660.4 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM